MANHATTAN SURGICAL HOSPITAL — History
CCN 170190 | 3-year financial timeline | COVID resilience: 68/100
🛡️ Public data only — no PHI permitted on this instance.
$42M
Latest Revenue (FY2022)
+7.9%
Revenue CAGR (3yr)
13.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $36M | $39M | $42M | +7.6% | +7.9% |
| Operating Expenses | $33M | $35M | $37M | +3.6% | +5.3% |
| Operating Margin | 8.7% | 9.7% | 13.1% | +34.3% | +22.4% |
| Net Income | $3M | $4M | $6M | +44.5% | +32.0% |
| Licensed Beds | 13 | 13 | 13 | +0.0% | +0.0% |
| Total Patient Days | 1,161 | 834 | 640 | -23.3% | -25.8% |
| Medicare Day % | 47% | 40% | 29% | -26.8% | -21.4% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 68/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +16.3% ($36M → $42M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+7.9%
This Hospital
+7.6%
State Avg
Latest Margin
13.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $45M | 15.3% |
| FY2024 (proj) | $48M | 17.4% |
| FY2025 (proj) | $51M | 19.6% |